Drugging the undruggable and other challenges targeting RNA - STAT

Drugging the undruggable and other challenges targeting RNA - STAT

STAT Plus: Drugging the undruggable and other challenges on the road to targeting RNA with pills

By REBECCA ROBBINS AND ADAM FEUERSTEIN AND DAMIAN GARDE

ARRAKIS

Michael Gilman is CEO of a startup showing early progress on a technology once thought impossible, but which may herald a new class of oral medicines.

READ MORE